Optinose Stock Analysis

OPTN -  USA Stock  

USD 2.19  0.01  0.45%

Optinose price slide over the last few months may encourage institutional investors to take a closer look at the company as it is trading at a share price of 2.19 on 407,300 in trading volume. The company directors and management were not very successful in positioning the company resources to exploit market volatility in December. However, diversifying your holdings with Optinose or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.29. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Optinose partners.
Please check Your Equity Center.

Optinose Stock Analysis 

 
Refresh
The Optinose stock analysis report makes it easy to digest most publicly released information about Optinose and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Optinose Stock analysis module also helps to analyze the Optinose price relationship with some important fundamental indicators such as market cap and management efficiency.

Optinose Stock Analysis Notes

About 64.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.71. Optinose had not issued any dividends in recent years. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Optinose operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 204 people. To find out more about Optinose contact Peter Miller at 267 364 3500 or learn more at https://www.optinose.com.

Optinose Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Optinose's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Optinose or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Optinose generated a negative expected return over the last 90 days
Optinose has high historical volatility and very poor performance
Optinose has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 68.49 M. Net Loss for the year was (90.53 M) with profit before overhead, payroll, taxes, and interest of 41.6 M.
Optinose currently holds about 84.23 M in cash with (79.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58.
Roughly 64.0% of the company shares are owned by institutional investors

Optinose Upcoming and Recent Events

Earnings reports are used by Optinose to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Optinose previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report10th of November 2020
Next Earnings Report4th of March 2021
Next Fiscal Quarter End30th of September 2020
Next Fiscal Year End4th of March 2021
Last Quarter Report30th of June 2020
Last Earning Announcement30th of September 2019

Optinose Largest EPS Surprises

Earnings surprises can significantly impact Optinose's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-08-12
2019-06-30-0.7375-0.660.077510 
2018-05-14
2018-03-31-0.7267-0.81-0.083311 
2018-11-13
2018-09-30-0.7075-0.610.097513 
View All Earnings Estimates

Optinose Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Optinose is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Optinose backward and forwards among themselves. Optinose's institutional investor refers to the entity that pools money to purchase Optinose's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fmr LlcCommon SharesM24 M
Massachusetts Financial Services CoCommon Shares1.8 M5.3 M
Opaleye Management IncCommon Shares1.6 M4.7 M
Vanguard Group IncCommon Shares1.5 M4.6 M
Gmt Capital CorpCommon Shares1.1 M3.3 M
Rice Hall James Associates LlcCommon Shares932.1 K2.8 M
Blackrock IncCommon Shares730.1 K2.2 M
Note, although Optinose's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Optinose Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 165.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Optinose's market, we take the total number of its shares issued and multiply it by Optinose's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Optinose Profitablity

Optinose's profitability indicators refer to fundamental financial ratios that showcase Optinose's ability to generate income relative to its revenue or operating costs. If, let's say, Optinose is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Optinose's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Optinose's profitability requires more research than a typical breakdown of Optinose's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (132.19) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (109.85) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -1.1.

Management Efficiency

The entity has return on total asset (ROA) of (30.05) % which means that it has lost $30.05 on every $100 spent on asset. This is way below average. Optinose management efficiency ratios could be used to measure how well optinose manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 23rd of January, Optinose holds the risk adjusted performance of (0.014862), and Coefficient Of Variation of (3,520). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Optinose, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Optinose, which can be compared to its competitors. Please check Optinose information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Optinose is priced some-what accurately, providing market reflects its current price of 2.19 per share. Please also confirm Optinose total risk alpha, which is currently at 0.2519 to check out the company can sustain itself at a future point.

Optinose Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of Optinose more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Optinose Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Optinose insiders, such as employees or executives, is commonly permitted as long as it does not rely on Optinose's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Optinose insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Optinose Predictive Daily Indicators

Optinose intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Optinose stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Optinose Forecast Models

Optinose time-series forecasting models is one of many Optinose's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Optinose's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Optinose Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Optinose stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Optinose shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Optinose. By using and applying Optinose Stock analysis, traders can create a robust methodology for identifying Optinose entry and exit points for their positions.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Optinose operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 204 people.

Current Optinose Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Optinose analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Optinose analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
17.25Strong Buy4Odds
Optinose current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Optinose analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Optinose stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Optinose, talking to its executives and customers, or listening to Optinose conference calls.
Optinose Analyst Advice Details

Optinose Stock Analysis Indicators

Optinose stock analysis indicators help investors evaluate how Optinose stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Optinose shares will generate the highest return on investment. By understating and applying Optinose stock analysis, traders can identify Optinose position entry and exit signals to maximize returns.
Quick Ratio2.02
Fifty Two Week Low1.4550
Revenue Growth41.40%
Shares Short Prior Month2.85M
Average Daily Volume Last 10 Day329.15k
Average Daily Volume In Three Month479.57k
Shares Percent Shares Out3.04%
Gross Margins87.12%
Short Percent Of Float4.21%
Forward Price Earnings-3.14
Float Shares33.52M
Fifty Two Week High4.8500
Enterprise Value To Ebitda-1.97
Fifty Day Average1.8375
Two Hundred Day Average2.7558
Enterprise Value To Revenue2.13
Please check Your Equity Center. Note that the Optinose information on this page should be used as a complementary analysis to other Optinose's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Optinose Stock analysis

When running Optinose price analysis, check to measure Optinose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Optinose is operating at the current time. Most of Optinose's value examination focuses on studying past and present price action to predict the probability of Optinose's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Optinose's price. Additionally, you may evaluate how the addition of Optinose to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Is Optinose's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Optinose. If investors know Optinose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Optinose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Optinose is measured differently than its book value, which is the value of Optinose that is recorded on the company's balance sheet. Investors also form their own opinion of Optinose's value that differs from its market value or its book value, called intrinsic value, which is Optinose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Optinose's market value can be influenced by many factors that don't directly affect Optinose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Optinose's value and its price as these two are different measures arrived at by different means. Investors typically determine Optinose value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Optinose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.